Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Shi, Chunwei ^a,c   Lu, Jia ^a,c   Wu, Wen ^a,c   Ma, Fanxin ^a,d   Georges, Joseph ^b   Huang, Hanju ^c   Balducci, James ^a   Chang, Yongchang ^b   Huang, Yao ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL SPECIFIC MOLECULE 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; BETA CATENIN; ECSM2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL JUNCTION; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGLYCOSYLATION; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL LINE; CELL MOTION; CELL STRAIN HEK293; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; GENE SILENCING; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT;

ORYCTOLAGUS CUNICULUS;

ANTIBODIES, MONOCLONAL; BETA CATENIN; CELL ADHESION; CELL AGGREGATION; CELL LINE; CELL MOVEMENT; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; INTERCELLULAR JUNCTIONS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 79959616373     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021482     Document Type: Article

References (60)

1. Folkman J, D'Amore PA, (1996) Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155.
2. Risau W, (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
3. Ma F, Zhang D, Yang H, Sun H, Wu W, et al. (2009) Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling. Genes Cells 14: 281-293.
4. Armstrong LJ, Heath VL, Sanderson S, Kaur S, Beesley JF, et al. (2008) ECSM2, an endothelial specific filamin a binding protein that mediates chemotaxis. Arterioscler Thromb Vasc Biol 28: 1640-1646.
5. Verma A, Bhattacharya R, Remadevi I, Li K, Pramanik K, et al. (2010) Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood 115: 4614-4622.
6. Ikeda K, Nakano R, Uraoka M, Nakagawa Y, Koide M, et al. (2009) Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc Natl Acad Sci U S A 106: 8227-8232.
7. Huminiecki L, Bicknell R, (2000) In silico cloning of novel endothelial-specific genes. Genome Res 10: 1796-1806.
8. Verissimo AR, Herbert JM, Heath VL, Legg JA, Sheldon H, et al. (2009) Functionally defining the endothelial transcriptome, from Robo4 to ECSCR. Biochem Soc Trans 37: 1214-1217.
9. Cross MJ, Claesson-Welsh L, (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22: 201-207.
10. Friesel RE, Maciag T, (1995) Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9: 919-925.
11. Klint P, Claesson-Welsh L, (1999) Signal transduction by fibroblast growth factor receptors. Front Biosci 4: D165-177.
12. Javerzat S, Auguste P, Bikfalvi A, (2002) The role of fibroblast growth factors in vascular development. Trends Mol Med 8: 483-489.
13. Huang Y, Kim SO, Yang N, Jiang J, Frank SJ, (2004) Physical and functional interaction of growth hormone and insulin-like growth factor-1 signaling elements. Mol Endocrinol 18: 1471-1485.
14. Perez-Moreno M, Fuchs E, (2006) Catenins: keeping cells from getting their signals crossed. Dev Cell 11: 601-612.
15. Xu W, Kimelman D, (2007) Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci 120: 3337-3344.
16. Tu Y, Huang Y, Zhang Y, Hua Y, Wu C, (2001) A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153: 585-598.
17. Schaller MD, (2001) Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 1540: 1-21.
18. Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, et al. (2002) Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 16: 598-600.
19. Huang C, Jacobson K, Schaller MD, (2004) MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
20. Hunger-Glaser I, Fan RS, Perez-Salazar E, Rozengurt E, (2004) PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser-910: dissociation from Tyr-397 phosphorylation and requirement for ERK activation. J Cell Physiol 200: 213-222.
21. Eide BL, Turck CW, Escobedo JA, (1995) Identification of Tyr-397 as the primary site of tyrosine phosphorylation and pp60src association in the focal adhesion kinase, pp125FAK. Mol Cell Biol 15: 2819-2827.
22. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, et al. (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14: 1680-1688.
23. Calalb MB, Polte TR, Hanks SK, (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinase. Mol Cell Biol 15: 954-963.
24. Hunger-Glaser I, Salazar EP, Sinnett-Smith J, Rozengurt E, (2003) Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J Biol Chem 278: 22631-22643.
25. Huang Y, Li X, Jiang J, Frank SJ, (2006) Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene 25: 7565-7576.
26. Gan Y, Shi C, Inge L, Hibner M, Balducci J, et al. (2010) Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29: 4947-4958.
27. Huang Y, Kim SO, Jiang J, Frank SJ, (2003) Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. J Biol Chem 278: 18902-18913.
28. Yan W, Bentley B, Shao R, (2008) Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. Mol Biol Cell 19: 2278-2288.
29. Brouillet S, Hoffmann P, Benharouga M, Salomon A, Schaal JP, et al. (2010) Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 21: 2832-2843.
30. Henriksen K, Karsdal M, Delaisse JM, Engsig MT, (2003) RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 278: 48745-48753.
31. Brizzi MF, Formato L, Dentelli P, Rosso A, Pavan M, et al. (2001) Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis. Circulation 103: 549-554.
32. McKay MM, Morrison DK, (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113-3121.
33. Rojas AI, Ahmed AR, (1999) Adhesion receptors in health and disease. Crit Rev Oral Biol Med 10: 337-358.
34. Joseph-Silverstein J, Silverstein RL, (1998) Cell adhesion molecules: an overview. Cancer Invest 16: 176-182.
35. Dejana E, (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261-270.
36. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B, (1994) Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 126: 247-258.
37. Falk MM, (2010) Adherens junctions remain dynamic. BMC Biol 8: 34.
38. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709.
39. Mitra SK, Hanson DA, Schlaepfer DD, (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
40. Zheng Y, Xia Y, Hawke D, Halle M, Tremblay ML, et al. (2009) FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell 35: 11-25.
41. Jiang X, Sinnett-Smith J, Rozengurt E, (2007) Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells. Cell Signal 19: 1000-1010.
42. Orian-Rousseau V, Ponta H, (2008) Adhesion proteins meet receptors: a common theme? Adv Cancer Res 101: 63-92.
43. Zhao J, Guan JL, (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28: 35-49.
44. Odintsova E, Sugiura T, Berditchevski F, (2000) Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 10: 1009-1012.
45. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, et al. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924.
46. Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, et al. (2002) Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 157: 149-160.
47. Brooks PC, Clark RA, Cheresh DA, (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571.
48. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, et al. (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502.
49. Simons M, (2004) Integrative signaling in angiogenesis. Mol Cell Biochem 264: 99-102.
50. Rapraeger AC, Krufka A, Olwin BB, (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708.
51. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM, (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
52. Bryant DM, Wylie FG, Stow JL, (2005) Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol Biol Cell 16: 14-23.
53. Suyama K, Shapiro I, Guttman M, Hazan RB, (2002) A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314.
54. Bazzoni G, Dejana E, (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901.
55. Dejana E, Orsenigo F, Lampugnani MG, (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122.
56. Lampugnani MG, Zanetti A, Corada M, Takahashi T, Balconi G, et al. (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161: 793-804.
57. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E, (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174: 593-604.
58. Wallez Y, Huber P, (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778: 794-809.
59. Spieker-Polet H, Sethupathi P, Yam PC, Knight KL, (1995) Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc Natl Acad Sci U S A 92: 9348-9352.
60. Huang ZY, Wu Y, Hedrick N, Gutmann DH, (2003) T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 23: 566-578.